Form 4: Willdan Group CFO Exercises and Sells Stock Options, Adjusting Personal Holdings

Sentiment:

Insider Transaction Report


Willdan Group, Inc.'s Executive VP and CFO, Creighton K. Early, exercised 5,000 stock options and simultaneously sold 5,000 shares of common stock, resulting in a net decrease of 5,000 shares in his direct beneficial ownership.

Summary

  • Creighton K. Early, Executive VP and CFO of Willdan Group, Inc. (WLDN), executed a transaction on May 28, 2025, involving the company's securities.
  • He exercised 5,000 stock options at an exercise price of $9.08 per share.
  • Concurrently, he sold 5,000 shares of common stock at a weighted average price of $53.28 per share, with individual sales ranging from $53.23 to $53.42.
  • Following these transactions, his direct beneficial ownership of common stock decreased from 77,071 shares to 72,071 shares.
  • The remaining 72,071 shares include 4,620 restricted stock units vesting in three equal installments on March 17, 2026, March 17, 2027, and March 17, 2028.
  • Also included are 2,800 restricted stock units vesting in two equal installments on March 20, 2026, and March 20, 2027.
  • Additionally, 7,600 shares of restricted stock are included, vesting on March 7, 2026.
  • Mr. Early continues to hold 7,764 unexercised stock options with an exercise price of $9.08, which vested between December 7, 2016, and December 7, 2018, and are set to expire on December 7, 2025.

Sentiment

Score: 5

Explanation: A neutral score as Form 4 filings are factual reports of insider transactions. While a sale by an executive can sometimes be viewed negatively, this appears to be a routine exercise-and-sell transaction for vested options, which is a common practice for executive compensation and personal financial management.

Positives

  • The transaction demonstrates the exercise of significantly in-the-money stock options, indicating a substantial gain between the exercise price of $9.08 and the sale price of $53.28 per share.

Negatives

  • The sale of 5,000 shares by a key executive reduces their direct equity stake in the company, which could be perceived as a slight reduction in alignment of interests by some investors, although it is a common practice for managing vested equity compensation.

Future Outlook

This Form 4 filing is a routine insider transaction report and does not provide any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing is a routine insider transaction report and does not provide information directly related to broader industry trends or the competitive landscape. It primarily reflects an individual executive's compensation management and personal financial planning.

Stakeholder Impact

  • Shareholders: The sale by a CFO could be interpreted differently by investors; some might view it as a routine personal financial management decision, while others might perceive it as a slight reduction in insider confidence. The net reduction in direct ownership is minor relative to the company's total shares outstanding.
  • Employees: No direct impact on employees is mentioned in this transaction report.

Next Steps

  • Future vesting of restricted stock units on March 17, 2026, March 20, 2026, March 17, 2027, March 20, 2027, and March 17, 2028, subject to continued service.
  • Expiration of remaining stock options on December 7, 2025.

Key Dates

DateDescription
12/07/2016First installment vesting date for the stock options that were exercised.
12/07/2017Second installment vesting date for the stock options that were exercised.
12/07/2018Third installment vesting date for the stock options that were exercised.
03/07/2026Vesting date for 7,600 shares of restricted stock.
03/17/2026First installment vesting date for 4,620 restricted stock units.
03/20/2026First installment vesting date for 2,800 restricted stock units.
03/17/2027Second installment vesting date for 4,620 restricted stock units.
03/20/2027Second installment vesting date for 2,800 restricted stock units.
03/17/2028Third installment vesting date for 4,620 restricted stock units.
05/28/2025Date of stock option exercise and common stock sale transaction.
05/29/2025Signature date of the Form 4 filing.
12/07/2025Expiration date for the remaining 7,764 stock options.

Keywords

Willdan Group, WLDN, SEC Form 4, Insider Trading, Stock Options, Executive Compensation, Share Sale, Beneficial Ownership, Creighton K. Early, CFO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.